Difference between revisions of "Rebimastat (BMS-275291)"
Jump to navigation
Jump to search
m |
m (Jwarner moved page BMS-275291 to Rebimastat (BMS-275291)) |
(No difference)
| |
Revision as of 19:56, 20 June 2023
Mechanism of action
From the NCI Drug Dictionary: A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called matrix metalloproteinase inhibitors (MMPIs).